[
    [
        {
            "time": "",
            "original_text": "[快讯]健帆生物:关于部分董事及监事减持计划实施完毕 拟减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "董事",
                    "监事",
                    "减持计划",
                    "实施完毕"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[快讯]健帆生物:关于部分董事及监事减持计划实施完毕 拟减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物：部分董事及监事累计减持0.29%股份，完成减持计划 减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "董事",
                    "监事",
                    "累计减持",
                    "0.29%"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：部分董事及监事累计减持0.29%股份，完成减持计划 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)：李得志及方丽华减持计划实施完毕 合计减持142.84万股 拟减持股份",
            "features": {
                "keywords": [
                    "健帆生物",
                    "李得志",
                    "方丽华",
                    "减持计划",
                    "实施完毕",
                    "142.84万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：李得志及方丽华减持计划实施完毕 合计减持142.84万股 拟减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]